Back to User profile » Dr Nobuki Furubayashi
Papers published by Dr Nobuki Furubayashi:
Early Progressive Disease During Nivolumab Plus Ipilimumab Therapy Predicts Poor Survival in Japanese Patients with Advanced Renal Cell Carcinoma: A Single-Center 12-Week Landmark Study
Furubayashi N, Tsujita J, Takayama A, Shiraishi Y, Nakamura M, Negishi T
Research and Reports in Urology 2026, 18:612372
Published Date: 5 June 2026
Clinical Outcomes of Avelumab Maintenance Following Full-Dose, Reduced-Dose Cisplatin, or Carboplatin-Based Chemotherapy in Advanced Urothelial Carcinoma
Furubayashi N, Tsujita J, Takayama A, Nakashima S, Nakamura M, Negishi T
Research and Reports in Urology 2025, 17:341-351
Published Date: 25 September 2025
The Eosinophil Changes, Efficacy and Safety of Pembrolizumab in Advanced Urothelial Carcinoma Patients with an Older Age and a Poor Performance Status
Furubayashi N, Minato A, Negishi T, Sakamoto N, Song Y, Hori Y, Tomoda T, Harada M, Tamura S, Kobayashi H, Wada Y, Kuroiwa K, Seki N, Fujimoto N, Nakamura M
OncoTargets and Therapy 2022, 15:1321-1330
Published Date: 5 November 2022
Association Between Immune-Related Adverse Events and Efficacy and Changes in the Relative Eosinophil Count Among Patients with Advanced Urothelial Carcinoma Treated by Pembrolizumab
Furubayashi N, Minato A, Negishi T, Sakamoto N, Song Y, Hori Y, Tomoda T, Harada M, Tamura S, Miura A, Komori H, Kuroiwa K, Seki N, Fujimoto N, Nakamura M
Cancer Management and Research 2022, 14:1641-1651
Published Date: 3 May 2022
The Association of Clinical Outcomes with Posttreatment Changes in the Relative Eosinophil Counts and Neutrophil-to-Eosinophil Ratio in Patients with Advanced Urothelial Carcinoma Treated with Pembrolizumab
Furubayashi N, Minato A, Negishi T, Sakamoto N, Song Y, Hori Y, Tomoda T, Tamura S, Kuroiwa K, Seki N, Fujimoto N, Nakamura M
Cancer Management and Research 2021, 13:8049-8056
Published Date: 24 October 2021
Organ-Specific Tumor Response to Pembrolizumab in Advanced Urothelial Carcinoma After Platinum-Based Chemotherapy
Furubayashi N, Negishi T, Sakamoto N, Shimokawa H, Morokuma F, Song Y, Hori Y, Tomoda T, Tokuda N, Seki N, Kuroiwa K, Nakamura M
OncoTargets and Therapy 2021, 14:1981-1988
Published Date: 18 March 2021
Organ-Specific Therapeutic Effect of Paclitaxel and Carboplatin Chemotherapy After Platinum-Based Chemotherapy and Pembrolizumab for Metastatic Urothelial Carcinoma
Furubayashi N, Negishi T, Miura A, Nakamura N, Nakamura M
Research and Reports in Urology 2020, 12:455-461
Published Date: 9 October 2020